Real-world experience with filgotinib for rheumatoid arthritis in Germany : A  retrospective chart review

CONCLUSIONS: In clinical practice in Germany, reasons for initiating filgotinib in patients with RA were related to dosing flexibility and general JAK inhibitor attributes. Filgotinib was used predominantly as monotherapy and was effective and generally well tolerated; however, longer-term data in larger, prospective cohorts are needed.PMID:38689038 | DOI:10.1007/s00393-024-01506-x

Source: Zeitschrift fur Rheumatologie - April 30, 2024 Category: Rheumatology Authors: Olaf Schultz Christoph Fiehn Christian Kneitz Nils Picker Daniel Kromer Monia Zignani Francesco De Leonardis Hans-Dieter Orzechowski Margot Gurrath Klaus Kr üger Source Type: research